Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Abacus dx Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (220)
Cancellation by sponsor (50)
COVID-19 test kit (1)

Date

2026 (17)
2025 (39)
2024 (22)
2023 (17)
2022 (9)
2021 (8)
2020 (13)
2019 (15)
2018 (18)
2017 (8)
2016 (7)
2015 (38)
2014 (17)
2013 (17)
2012 (10)
2011 (13)
2007 (3)

Search

Sponsor content

271 result(s) found, displaying 11 to 20

Abacus dx Pty Ltd - Histology and Cytology ancillary IVDs Cancelled under Section 41GL(d) of the Act

26 June 2026

Cancellation by sponsor

Requested by Abacus dx Pty Ltd
Abacus dx Pty Ltd - Immunohistology cell marker IVDs Cancelled under Section 41GL(d) of the Act

26 June 2026

Cancellation by sponsor

Requested by Abacus dx Pty Ltd
Abacus dx Pty Ltd - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

26 June 2026

Cancellation by sponsor

Requested by Abacus dx Pty Ltd
Abacus dx Pty Ltd - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

26 June 2026

Cancellation by sponsor

Requested by Abacus dx Pty Ltd
Abacus dx Pty Ltd - 5415219A0270CC - Idylla EGFR Mutation Test (524627)

18 March 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abacus dx Pty Ltd - 5415219A0270CC - Idylla EGFR Mutation Test.
Abacus dx Pty Ltd - LeukoStrat CDx FLT3 Mutation Assay - Acquired genetic alteration IVDs (523711)

20 February 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abacus dx Pty Ltd - LeukoStrat CDx FLT3 Mutation Assay - Acquired genetic alteration IVDs.
Abacus dx Pty Ltd - Pneumocystis IVDs (523257)

10 February 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abacus dx Pty Ltd - Pneumocystis IVDs.
Abacus dx Pty Ltd - Multiple infectious organism IVDs (521656)

17 December 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abacus dx Pty Ltd - Multiple infectious organism IVDs.
Abacus dx Pty Ltd - General laboratoryware IVDs (521544)

15 December 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abacus dx Pty Ltd - General laboratoryware IVDs.
Abacus dx Pty Ltd - Instrument/analyser IVDs (511487)

9 September 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abacus dx Pty Ltd - Instrument/analyser IVDs.

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.